These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29520987)

  • 1. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M; Elisei W; Tursi A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
    Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
    Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
    Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
    Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mesalazine in diverticular disease.
    Di Mario F; Comparato G; Fanigliulo L; Aragona G; Cavallaro LG; Cavestro GM; Franzé A
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S155-9. PubMed ID: 16885700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study.
    Tursi A; Di Mario F; Brandimarte G; Elisei W; Picchio M; Loperfido S; Dal Bo' N; Ferrara F; Marcello R; Heras Salvat H; Scarpignato C
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3244-8. PubMed ID: 24338468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mesalazine treatment effective in the prevention of diverticulitis? A review.
    Stefanelli G; Viscido A; Valvano M; Vernia F; Frieri G; Ashktorab H; Latella G
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8164-8176. PubMed ID: 32767345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
    Tursi A; Picchio M
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):409-11. PubMed ID: 27689212
    [No Abstract]   [Full Text] [Related]  

  • 13. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.
    Carter F; Alsayb M; Marshall JK; Yuan Y
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009839. PubMed ID: 28973845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A; Papa A; Danese S
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
    Kruis W; Meier E; Schumacher M; Mickisch O; Greinwald R; Mueller R;
    Aliment Pharmacol Ther; 2013 Apr; 37(7):680-90. PubMed ID: 23414061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.
    Tursi A; Brandimarte G; Giorgetti GM; Elisei W
    J Clin Gastroenterol; 2006 Apr; 40(4):312-6. PubMed ID: 16633103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
    Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
    Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
    Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
    J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A
    Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.